Serum sickness and severe angioedema following rituximab therapy in RA.
Ashok
A
Kumar
Kundan
K
Khamkar
Hemant
H
Gopal
D000799:Angioedema / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D058846:Antibodies, Monoclonal, Murine-Derived / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D039563:Histamine H1 Antagonists, Non-Sedating / Q000627:therapeutic use; D006801:Humans; D008875:Middle Aged; D000069283:Rituximab; D012713:Serum Sickness / Q000139:chemically induced* / Q000175:diagnosis / Q000188:drug therapy; D012720:Severity of Illness Index; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D018501:Antirheumatic Agents; D005938:Glucocorticoids; D039563:Histamine H1 Antagonists, Non-Sedating; D000069283:Rituximab